Population based study of use of anticoagulants among patients with atrial fibrillation in the community

British Medical Journal

Volumn 314, Issue 7093, 1997, Pages 1529-1530

  Sudlow, Mark ^a,b   Rodgers, Helen ^a,c   Kenny, Rose Anne ^d,e   Thomson, Richard ^d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Health Services Research   (United Kingdom)

^c Stroke Medicine and Services

^d Medical School

^e Department of Geriatric Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; HEMOGLOBIN; WARFARIN;

AGED; ARTICLE; DRUG CONTRAINDICATION; DRUG USE; HEART ATRIUM FIBRILLATION; HEMATEMESIS; HEMATURIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; STROKE;

EID: 0030949225     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.314.7093.1529     Document Type: Article

References (5)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994; 154:1449-57.
2. Lip GYH, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. Br Heart J 1994;71:92-5.
3. O'Connell JE, Gray CS. Atrial fibrillation and stroke prevention in the community. Age Ageing 1996;25:307-9.
4. Sweeney KG, Gray DP, Steele R, Evans P. Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract 1995;45:153-8.
5. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Final results. Circulation 1991;84:527-39.